Welcome to the winter 2009 issue of CABA Connect, the newsletter of Chinese-American BioMedical Association. We invite you to take a look at this publication for what we have done in the past several months and visit .cabaweb.org to learn more about our organization and many upcoming events.
This issue summarizes the major activities organized, co-organized or co-sponsored by CABA from August 2009 to end of the year. Highlights of these events include “2009 New England Chinese Professionals’ Summer Outing on Aug 8th at Hopkinton State Park; “2009 CABA Technology, Investment and Entrepreneurship Symposium” on Nov 14 in Boston; and “2009 CABA Medical Devices and Diagnostics Symposium” on Dec 5 at MIT. The majority of the news reports are from the hands of our dedicated and productive Executive Committee members and coordinators, the exact team who organized and executed these cultural and professional events in a very short period of time. We also included some reports in Chinese previously published by reporters of our media partners.
In this issue, you will also find a selection of news by Chinese media covering CABA’s activities in China. These activities include CABA delegation’s recent visits of several bio-industrial parks and enterprises in Shanghai, Wuxi, Wuhan and Changsha, and CABA’s active involvement as a key organizer or participant of some large international conferences or forums held in mainland China, such as Bio-forum of the 10th Hua-Chuang-Hui (华创会) in Wuhan and World Pharmaceuticals (China) Summit 2009 in Shanghai. The increased publicity of CABA reflects the increased influence and impact of our organization in promoting the collaboration between US and China in biopharmaceutical industries.
The year of 2010 will be another busy year for this young but dynamic organization. Among the many important events under preparations, please mark your calendar for the following two: 1) the New England Chinese Professionals Lunar New Year Gala and the Community Enrichment Forum at Marriot Newton Hotel on February 14 2010, which is co-organized by 11 New England Based Chinese professional organizations aiming to enrich each other, to build bonds within our communities and to celebrate our common cultural and historic heritage; and 2) the 3rd CABA annual conference at MIT Faculty Club on April 10th, 2010. Please check our website for more information.
As China's capital, Beijing is the political, cultural, international and domestic exchange center. It is China’s most economically active city with a huge development potential. Beijing gathers a large number of national research institutes and universities full of talented people and is the best city in China in terms of intellectual property protection. Bio-pharmaceutical industry is one of Beijing's pillar industries. Its biomedical industry has seen tremendous growth and generates great opportunities. A delegation, led by Beijing promotional bureau, will be here on July 2~3 to meet you and explore potential collaborations.
时间: July 3, 2010(Sat.) 9:00am--3:00pm 地点: MIT Faculty Club,50 Memorial Drive, Bldg E52, 6th Floor, Cambridge, MA
Agenda: 9:00--12:00pm Introduction of Beijing Opportunities for Collaboration in Bio/Pharma field 12:00--1:00pm Lunch(free for registered participants) 1:00--4:00pm Round-table discussions
The delegation will have time for 1-on-1 meetings on July 2(Friday). If you are interested in 1-on-1 talk with any member of the delegation, please fill up the short sign-up form and return it to Dr. Fred Hu (yhu1995@yahoo.com ) by June 25th, he will try to allocate a meeting slot for you if available. The meeting will be at Hyatt Regency Cambridge at 575 Memorial Drive, Cambridge, MA 02139.
Northeastern Section of American Chemical Society (NESACS) and Chinese -American BioMedical Association (CABA) are organizing a scientific symposium on Saturday, May 22 at Holiday Inn of Woburn, MA (15 Middlesex Canal Park Road). This symposium will feature "Drug R&D in China: Status, Opportunity, International Collaboration and Challenges". Comparing to the well-established Chinese Pharmaceutical CRO services sector, China's innovative drug R&D has shown its momentum only in recent several years. Prominent academic professors and seasoned industrial scientists and executives from both China and US will share their views on China's drug R&D and the impact to the global pharmaceutical industry. Don't miss this unique opportunity to learn about China's drug R&D status and to network with leaders in this field.
NESACS and CABA members will enjoy a discount rate ($30 for ACS members, $20 for CABA members, $35 for non-members) to attend this symposium.
Pre-registration is required. Please register before May 19 by accepting the Evite invitation below. Please put down your full name and affiliation so that a proper nametag can be prepared for you by the organizers beforehand. http://www.evite.com/app/publicUrl/SIEVVUIRCDIGGZEPGSVP/ChinaRnD
Attached is the flyer. For more information and updates, please go to www.NESACS.org.
DRUG R&D IN CHINA - Status, Opportunity, International Collaboration and Challenges
Organizer by Northeastern Section of American Chemical Society (NESACS) Chinese-American BioMedical Association (CABA)
Saturday, May 22nd, 2010 Holiday Inn (15 Middlesex Canal Park Road, Woburn, MA)
Program
8:30~9:00 Registration
9:00~9:05 Welcome Dr. Liming Shao (Chair of Medicinal Chemistry, NESACS)
9:05~9:15 Opening Remarks Dr. John Neumeyer (Harvard Medical School, McLean Hospital)
9:15~12:00 Session I Drug discovery in China and Chinese pharmaceutical industry - Status and opportunity, Chair, Dr. Yuan Wang (Director, Discovery, Oncology-PCU, Eisai)
9:20~10:00 Drug Discovery in China - An Insider’s View Dr. Jingkang Shen (Professor, Shanghai Institute of Materia Medica, Chinese Academy of Science)
10:00~10:30 Trends of World Drug R&D - A Global View of Chinese Pharmaceutical Industry, Christopher-Paul Milne, DVM, MPH, JD (Associate Director, Center for the Study of Drug Development, Tufts University)
10:30~10:45 Break
10:45~11:15 New drug discovery: starting from the old ones, Dr. Hongbing Sun (Professor of Medicinal Chemistry, Director of Center of Drug Discover, China Pharmaceutical University)
11:15~11:45 Build up discovery capability, a story from a small biotech company, Dr. Michael Song (COO/CSO, KBP Bioscience, China)
11:45~1:00 Lunch
Session II 1:00-3:00 Leveraging China’s drug discovery through international collaboration, Chair, Dr. Zhijian Lu (Director, Extramural Partnered Research, Asia, Global Biotherapeutics Technologies, Pfizer)
1:00~1:30pm Building a library of authenticated, quality controlled, source-documented Traditional Chinese Medicine (TCM) plants at Harvard Medical School: an international collaboration to identify new therapeutic opportunities, Dr. Bruce Littlefield (Harvard University, Medical School)
1:30~2:00pm Current Status and Future Directions of Simcere’s Pharmaceutical R&D, Dr. Peng Wang (CSO, Simcere Pharmaceutical Group)
2:00~2:30pm Partnering for Success: An Overview of Pfizer’s R&D Innovation Efforts in China, Dr. Yuan-Hua Ding (Director, Head of External R&D Innovation – Asia, Pfizer Biotherapeutics Research and Development)
2:30~3:00pm Establishment of a world-leading Oncology R&D innovation group in Shanghai: the AstraZeneca experience, Dr. Luciene Ronco (Global Director of Discovery Medicine and Translational Science, AstraZeneca)
3:00~3:30 Panel Discussion, Moderator, Dr. Chaoyang Dai, (President, CABA)
3:30~4:00 Break
4:00~6:00 Session III Challenges and opportunities Drug R&D in China. Chair, Dr. Yibin Xiang (Sr. Director, Medicinal Chemistry, Genzyme)
4:00~4:30 It is all possible - from Tianyuan’s success story to look at opportunity in drug R&D in China, Dr. Sam Liao (Head of Business Development & Licensing, Novartis Vaccines & Diagnostics)
4:30~5:00 Development of Multi-Targeted siRNA Therapeutics with Nanoparticle-Enhanced Delivery Systems, Patrick Y. Lu, Ph.D. (Founder, President and CEO of Sirnaomics, Inc)
5:00~5:30 Is IP still an issue for drug R&D in China? - Recent changes and progress for IP protection in China, Philip Zhang, Ph.D. (Esq. Co-Founder of Principal Milstein Zhang & Wu LLC)
5:30~6:00 To pursue IP protection in China - understanding the commons and differences of IP protection between US and China through case studies, Michael McGurk, Partner (Finnegan)
6:00~7:00 Social Hour Reception (Sponsored by Sundia MediTech Company)
The Suzhou-Nantong Science and Technology Park (STP) has a delegation to Boston on May 14. Su-Tong Park is a joint venture of Singapore-Suzhou Industry Park (SIP)-Nantong Economic and Technological Development Area (NETDA). It’s located at the north bank of Yangtze River, forming a ‘Golden Triangle” with Shanghai and Suzhou. STP will be built as a livable, eco-friendly high tech city, focusing at areas such as green energy, biopharma, electronics and informatics, new materials and modern service industry. STP is a State-level Park and will be able provide companies with various benefits including tax incentive authorized by the State.
Nantong is considered as the first industrialized city with sophisticated education system in modern Chinese history. It currently has 6 high education institutes and 29 professional colleges with more than 50,000 students. SuTong Science and Technology Park (STP) is the High Standard Start-up Fort at Yangtze Delta. When launching your business in China, let STP be your partner!
A Hubei delegation is coming to Boston to recruit talents on April 24 (Saturday). The delegates would like to meet overseas professionals, students and scholars. They will introduce Hubei’s recent development, especially in the high-tech fields, and its favorable policies towards the overseas talents including national “1000 Talents Plan”, Hubei “3551 plan” and “100 Talents Plan”. This is the first time Hubei sends such a high level recruiting delegation to Boston. You are cordially welcome to join this event to explore opportunities in Hubei!
Where: Charles View Ballroom(16th Flr.), Hyatt Regency Cambridge, 575 Memorial Dr., Cambridge, MA02139
When: Saturday, April 24th • 9:00 -10:00pm Registration and networking • 10:00 -12:00pm Greetings and introduction by the delegation • 12:00-2:00pm Lunch and Networking • 2:00-5:00pm 1-on-1 meetings with the delegates
Parking at Hyatt parking lot is free for meeting participants, please validate your tickets at the Charles view Ballroom with one of the meeting organizers.
CABA welcomes the Hubei delegation and is a co-organizer of the event. If you have any questions, especially if you would like to meet 1-on-1 with certain delegation members, please contact Drs. Chaoyang Dai chaoyangdai@hotmail.com, Zhiyong Yang at zyyang02@yahoo.com.
Article ID : 70